Literature DB >> 33761896

EML4-ALK induces cellular senescence in mortal normal human cells and promotes anchorage-independent growth in hTERT-transduced normal human cells.

Akihiko Miyanaga1,2, Masaru Matsumoto1,2, Jessica A Beck1, Izumi Horikawa1, Takahiro Oike1, Hirokazu Okayama1, Hiromi Tanaka3, Sandra S Burkett4, Ana I Robles1, Mohammed Khan1, Delphine Lissa1, Masahiro Seike2, Akihiko Gemma2, Hiroyuki Mano5, Curtis C Harris6.   

Abstract

BACKGROUND: Chromosomal inversions involving anaplastic lymphoma kinase (ALK) and echinoderm microtubule associated protein like 4 (EML4) generate a fusion protein EML4-ALK in non-small cell lung cancer (NSCLC). The understanding of EML4-ALK function can be improved by a functional study using normal human cells.
METHODS: Here we for the first time conduct such study to examine the effects of EML4-ALK on cell proliferation, cellular senescence, DNA damage, gene expression profiles and transformed phenotypes.
RESULTS: The lentiviral expression of EML4-ALK in mortal, normal human fibroblasts caused, through its constitutive ALK kinase activity, an early induction of cellular senescence with accumulated DNA damage, upregulation of p16INK4A and p21WAF1, and senescence-associated β-galactosidase (SA-β-gal) activity. In contrast, when EML4-ALK was expressed in normal human fibroblasts transduced with telomerase reverse transcriptase (hTERT), which is activated in the vast majority of NSCLC, the cells showed accelerated proliferation and acquired anchorage-independent growth ability in soft-agar medium, without accumulated DNA damage, chromosome aberration, nor p53 mutation. EML4-ALK induced the phosphorylation of STAT3 in both mortal and hTERT-transduced cells, but RNA sequencing analysis suggested that the different signaling pathways contributed to the different phenotypic outcomes in these cells. While EML4-ALK also induced anchorage-independent growth in hTERT-immortalized human bronchial epithelial cells in vitro, the expression of EML4-ALK alone did not cause detectable in vivo tumorigenicity in immunodeficient mice.
CONCLUSIONS: Our data indicate that the expression of hTERT is critical for EML4-ALK to manifest its in vitro transforming activity in human cells. This study provides the isogenic pairs of human cells with and without EML4-ALK expression.

Entities:  

Keywords:  Anchorage-independent growth; DNA damage; EML4-ALK; Lung cancer; Senescence; hTERT

Mesh:

Substances:

Year:  2021        PMID: 33761896      PMCID: PMC7992817          DOI: 10.1186/s12885-021-07905-6

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


  57 in total

1.  ALK fusion genes in children with atypical myeloproliferative leukemia.

Authors:  S Röttgers; M Gombert; A Teigler-Schlegel; K Busch; U Gamerdinger; R Slany; J Harbott; A Borkhardt
Journal:  Leukemia       Date:  2010-04-29       Impact factor: 11.528

2.  Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication.

Authors:  Raffaella Di Micco; Marzia Fumagalli; Angelo Cicalese; Sara Piccinin; Patrizia Gasparini; Chiara Luise; Catherine Schurra; Massimiliano Garre'; Paolo Giovanni Nuciforo; Aaron Bensimon; Roberta Maestro; Pier Giuseppe Pelicci; Fabrizio d'Adda di Fagagna
Journal:  Nature       Date:  2006-11-30       Impact factor: 49.962

3.  The STAT3-IGFBP5 axis is critical for IL-6/gp130-induced premature senescence in human fibroblasts.

Authors:  Hirotada Kojima; Hiroyuki Kunimoto; Toshiaki Inoue; Koichi Nakajima
Journal:  Cell Cycle       Date:  2012-02-15       Impact factor: 4.534

4.  The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence.

Authors:  Frédérick A Mallette; Marie-France Gaumont-Leclerc; Gerardo Ferbeyre
Journal:  Genes Dev       Date:  2007-01-01       Impact factor: 11.361

5.  Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

Authors:  M Serrano; A W Lin; M E McCurrach; D Beach; S W Lowe
Journal:  Cell       Date:  1997-03-07       Impact factor: 41.582

6.  Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas.

Authors:  Hirokazu Okayama; Takashi Kohno; Yuko Ishii; Yoko Shimada; Kouya Shiraishi; Reika Iwakawa; Koh Furuta; Koji Tsuta; Tatsuhiro Shibata; Seiichiro Yamamoto; Shun-ichi Watanabe; Hiromi Sakamoto; Kensuke Kumamoto; Seiichi Takenoshita; Noriko Gotoh; Hideaki Mizuno; Akinori Sarai; Shuichi Kawano; Rui Yamaguchi; Satoru Miyano; Jun Yokota
Journal:  Cancer Res       Date:  2011-11-11       Impact factor: 12.701

Review 7.  The INK4A/ARF locus and its two gene products.

Authors:  N E Sharpless; R A DePinho
Journal:  Curr Opin Genet Dev       Date:  1999-02       Impact factor: 5.578

8.  Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of Cancer.

Authors:  Hengyu Lu; Nicole Villafane; Turgut Dogruluk; Caitlin L Grzeskowiak; Kathleen Kong; Yiu Huen Tsang; Oksana Zagorodna; Angeliki Pantazi; Lixing Yang; Nicholas J Neill; Young Won Kim; Chad J Creighton; Roel G Verhaak; Gordon B Mills; Peter J Park; Raju Kucherlapati; Kenneth L Scott
Journal:  Cancer Res       Date:  2017-05-16       Impact factor: 12.701

Review 9.  p53: guardian of the genome and policeman of the oncogenes.

Authors:  Alejo Efeyan; Manuel Serrano
Journal:  Cell Cycle       Date:  2007-05-28       Impact factor: 4.534

10.  Combined effect of ALK and MEK inhibitors in EML4-ALK-positive non-small-cell lung cancer cells.

Authors:  J Tanizaki; I Okamoto; K Takezawa; K Sakai; K Azuma; K Kuwata; H Yamaguchi; E Hatashita; K Nishio; P A Janne; K Nakagawa
Journal:  Br J Cancer       Date:  2012-01-12       Impact factor: 7.640

View more
  2 in total

Review 1.  Epstein-Barr Virus Infection in Lung Cancer: Insights and Perspectives.

Authors:  Julio C Osorio; Rancés Blanco; Alejandro H Corvalán; Juan P Muñoz; Gloria M Calaf; Francisco Aguayo
Journal:  Pathogens       Date:  2022-01-21

2.  The respiratory microbiome associated with chronic obstructive pulmonary disease comorbidity in non-small cell lung cancer.

Authors:  Masamitsu Shimizu; Akihiko Miyanaga; Masahiro Seike; Kuniko Matsuda; Masaru Matsumoto; Rintaro Noro; Kazue Fujita; Yoko Mano; Nobuhiko Furuya; Kaoru Kubota; Akihiko Gemma
Journal:  Thorac Cancer       Date:  2022-05-17       Impact factor: 3.223

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.